<DOC>
	<DOCNO>NCT00703157</DOCNO>
	<brief_summary>Prospective randomize observational trial compare efficacy circumferential pulmonary vein ostia ablation use surgical versus catheter technique treatment paroxysmal atrial fibrillation . Success rate determine REVEAL-XT ( AF implantable monitoring device ) .</brief_summary>
	<brief_title>Surgical Catheter Ablation Lone Atrial Fibrillation ( AF ) Patients</brief_title>
	<detailed_description>Title : Surgical Catheter Ablation patient Lone Atrial Fibrillation : determination acute long term SUCCESS ( SCALAF-success trial ) . Background : Anti-arrhythmic drug use daily practice treat patient paroxysmal idiopatic AF . Often origin AF find muscle sleeve run pulmonary vein . Drug treatment always successful prone evoke negative side effect . The surgical MAZE procedure apply past , time consuming , cumbersome technique , often associate significant complication . Cardiac radio-frequency ablation offer alternative , easy less time consume treatment : lesion prevent normal electrical wave front propagation might stop continuation atrial fibrillation wave front . Ablation implement use special catheter insert via groin use Medtronic CarbioblateÂ® Surgical Ablation System apply via minimal invasive surgical technique . Purpose : Compare effectiveness pulmonary vein isolation achieve via catheter via surgical ablation technique treat patient paroxysmal lone AF . Study design : A prospective , randomized multi-center observational study . Patients : Patients suffer paroxysmal idiopatic AF ( associate underlie structural heart disease ) comply follow inclusion criterion : - minimally one document AF-episode last 6 month ; - refractory least 2 class I III anti-arrhythmic drug ; - age &gt; 18 year Intervention : Patients randomize either surgical catheter ablation group receive indicate treatment . During critical assessment period , patient wean anti-arrhythmic medication . Primary endpoint : Reduction AF occurrence measure AF-burden parameter critical period 3 6 month post-ablation . AF burden measure automatically mean Reveal XT , implant study enrolment document baseline characteristic . Secondary endpoint : - Failure therapy require re-interventions ; - Duration , burden cost ablation procedure : - Reduction frequency , duration level severity AF symptom ; - Symptoms associate AF ; - Reduced necessity anti-arrhythmic anticoagulant medication ; - Left atrial dimension contractility - Adverse event associate ablation therapy ; - Occurrence clinical adverse event ( TIA , CVA , bleeds , tamponade , MI ) 3 , 6 , 12 24 month follow Risk assessment : Possible side effect : irregular heart rhythm , pericardial fluid , stroke , heart infarct , disturbances conduction system heart , local pain site incision , heart failure reduce pump function heart . Possible benefit : Regulation heart rhythm without apply MAZE procedure open thorax . Reduction relieve symptom associate AF . Partial complete reduction anti-arrhythmic medication . Control anti-coagulant medication . Improved quality life patient . Hospital follow : Follow-up visit plan study entrance Reveal XT implant , assessment baseline , application ablation therapy , discharge hospital , 3 , 6 , 12 24 month post-ablation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient document Paroxysmal AF define ACC/AHA/ESC guideline Minimal one document AF episode last 6 month Refractory minimal two Class I III antiarrhythmic drug Age &gt; 18 year Signed dated Patient Informed Consent . Patient tolerate anticoagulation therapy ( Warfarin/Coumadin ) Patient structural heart disease Ejection fraction &lt; 40 % Echocardiographic evidence leave atrium &gt; 45 mm ( parasternal axis ) Patients amiodarone , patient know intolerant amiodarone Dextrocardia , current endocarditis , systemic infection , renal failure Patient know cerebrovascular disease , include history stroke , CVA TIA Pregnancy enrolment ; plan pregnancy within follow period Patient life expectancy le 1 year The subject participate another device drug study The patient unable and/or unwilling cooperate study procedure require follow visit Echocardiographic ( TTE ) evidence presence leave atrial thrombus Previous ( cardio ) thoracic surgery Previous leave atrial ablation Patients permanent persistent AF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>